Related Experiment Videos
Novel human histamine H(3) receptor antagonists
Chandra Shah1, Laura McAtee, J Guy Breitenbucher
1Johnson and Johnson Pharmaceutical Research and Development, L.L.C., San Diego, CA 92121, USA.
Bioorganic & Medicinal Chemistry Letters
|October 24, 2002
Summary
Researchers identified novel histamine H(3) receptor antagonists using high throughput screening. The lead compounds were potent, selective, orally bioavailable, and penetrated the blood-brain barrier effectively.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Neuroscience
Background:
- The histamine H(3) receptor is a G protein-coupled receptor involved in regulating neurotransmitter release in the central nervous system.
- Histamine H(3) receptor antagonists have therapeutic potential for various neurological and psychiatric disorders.
Purpose of the Study:
- To identify novel, potent, and selective histamine H(3) receptor antagonists.
- To discover compounds with favorable pharmacokinetic properties, including oral bioavailability and blood-brain barrier penetration.
Main Methods:
- High throughput screening (HTS) of a compound library utilizing a recombinant human histamine H(3) receptor assay.
- Lead compound evaluation, including assessment of potency, selectivity, oral bioavailability, and blood-brain barrier penetration.
Main Results:
- Identification of novel histamine H(3) receptor antagonists through HTS.
- Optimization of lead compounds resulted in potent and selective antagonists.
- Selected compounds demonstrated favorable oral bioavailability and blood-brain barrier penetration.
Conclusions:
- High throughput screening is an effective strategy for discovering histamine H(3) receptor antagonists.
- The identified compounds represent promising drug candidates for further development.
- Favorable pharmacokinetic profiles suggest potential therapeutic applications in CNS disorders.